Endoscopy 2006; 38(8): 793-796
DOI: 10.1055/s-2006-944602
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Troponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm

D.  F.  Martin1 , H.-U.  Laasch2 , A-M.  Kelly3 , R.  Hammonds4 , L.  Wilbraham1 , S.  Sastry5 , A.  England1
  • 1Academic Dept. of Gastrointestinal Radiology, South Manchester University Hospitals, Manchester, United Kingdom
  • 2Dept. of Radiology, Christie Hospital, Manchester, United Kingdom
  • 3Dept. of Biochemistry, South Manchester University Hospitals, Manchester, United Kingdom
  • 4Dept. of Gastroenterology, North Manchester General Hospital, Manchester, United Kingdom
  • 5Dept. of Cardiology, Manchester Royal Infirmary, Manchester, United Kingdom
Further Information

Publication History

Submitted 5 February 2006

Accepted after revision 6 June 2006

Publication Date:
28 August 2006 (online)

Abstract

Background and study aims: It is well recognized that myocardial ischemia can occur during endoscopic retrograde cholangiopancreatography (ERCP). Acute arrhythmias and ST segment changes have been reported by a number of authors, but the longer-term sequelae with regard to permanent myocardial damage are not known. The aim of this study was to determine the presence or absence of significant injury to the heart muscle.
Patients and methods: Sixty-two patients undergoing therapeutic ERCP were assessed clinically and with electrocardiography (ECG) for the presence of ischemic heart disease before the procedure. Extensive intraprocedural monitoring was carried out, postprocedural ECGs were recorded, and serum troponin T levels were measured. The ECGs were evaluated blindly by a single cardiologist.
Results: In 61 of the 62 patients, no changes were observed between the ECGs before and after the procedure. One patient had postprocedural T wave inversion but a normal troponin T level, excluding myocardial damage. One patient with mild renal insufficiency and treated heart failure had borderline troponin T elevation (0.05μg/l) but no ECG changes. No complications of ERCP occurred.
Conclusions: Whilst ECG and rhythm changes indicating transient myocardial ischemia do occur during ERCP, there is no evidence that myocardial damage takes place as a consequence of this.

References

  • 1 Blaszyk K, Baszko A, Ochotny R. et al . ECG Holter monitoring during endoscopic examination.  Kardiol Pol. 1990;  33: (8) 8-12
  • 2 Kounis N G, Zavras G M, Papadaki P J. et al . Electrocardiographic changes in elderly patients during endoscopic retrograde cholangiopancreatography.  Can J Gastroenterol. 2003;  17 539-544
  • 3 Christensen M, Milland T, Rasmussen V. et al . ECG changes during endoscopic retrograde cholangio-pancreatography and coronary artery disease.  Scand J Gastroenterol. 2005;  40 713-720
  • 4 Christensen M, Hendel H W, Rasmussen V. et al . Endoscopic retrograde cholangiopancreatography causes reduced myocardial blood flow.  Endoscopy. 2002;  34 797-800
  • 5 Christensen M, Rasmussen V, Schulze S. et al . Vagal withdrawal during endoscopic retrograde cholangiopancreatography.  Scand J Gastroenterol. 2000;  35 96-101
  • 6 Christensen M, Reinert R, Rasmussen V. et al . Factors that affect the variability in heart rate during endoscopic retrograde cholangiopancreatography.  Eur J Surg. 2002;  168 546-551
  • 7 Babuin L, Jaffe A S. Troponin: the biomarker of choice for the detection of cardiac injury.  CMAJ. 2005;  173 1191-1202
  • 8 Heidenreich P A, Alloggiamento T, Melsop K. et al . The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis.  J Am Coll Cardiol. 2001;  38 478-485
  • 9 Fisher J D. New York Heart Association classification.  Arch Intern Med. 1972;  129 836
  • 10 American Society of Anesthesiologists . New classification of physical status.  Anesthesiology. 1963;  24 111
  • 11 Bell J K, Laasch H U, Wilbraham L. et al . Bispectral index monitoring for conscious sedation in intervention: better, safer, faster.  Clin Radiol. 2004;  59 1106-1113
  • 12 .Safety and sedation during endoscopic procedures: guidelines of the British Society of Gastroenterology,. 2003. http://http://www.bsg.org.uk/pdf_word_docs/sedation.doc
  • 13 Rosenberg J, Jorgensen L N, Rasmussen V. et al . Hypoxaemia and myocardial ischaemia during and after endoscopic cholangiopancreatography: call for further studies.  Scand J Gastroenterol. 1992;  27 717-720
  • 14 Holm C, Rosenberg J. Pulse oximetry and supplemental oxygen during gastrointestinal endoscopy: a critical review.  Endoscopy. 1996;  28 703-711
  • 15 Rosenberg J, Overgaard H, Andersen M. et al . Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography.  BMJ. 1996;  313 258-261
  • 16 Christensen M, Matzen P, Schulze S. et al . Complications of ERCP: a prospective study.  Gastrointest Endosc. 2004;  60 721-731
  • 17 Johnston S D, McKenna A, Tham T C. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.  Endoscopy. 2003;  35 1039-1042
  • 18 Rigg J D, Watt T C, Tweedle D E. et al . Oxygen saturation during endoscopic retrograde cholangiopancreatography: a comparison of two protocols of oxygen administration.  Gut. 1994;  35 408-411

D. F. Martin, M. D.

Academic Dept. of Gastrointestinal Radiology

South Manchester University Hospitals · Manchester M23 9LT · United Kingdom

Fax: +44-161-291-6201

Email: derrick.martin@smtr.nhs.uk

    >